The current valuation score of Benitec Biopharma Inc is 8.43, ranking 131 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.96, which is -245.77% below the recent high of 20.35 and -36.68% above the recent low of -19.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.